Also trades as: CYYNF (OTC) · $vol 0M
CYP.AX ASX
Cynata Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: -21.4%
YTD: -97.1%
1Y: -94.9%
3Y: -91.5%
5Y: -98.1%
A$0.01 ($0.01)
-0.00 (-0.00%)
Weekly Expected Move ±3.4%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTMA$2M
Revenue
-52.5% YoY
A$-18M
Net Income
+23.1% YoY
A$-15M
Free Cash Flow
+36.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-541.7%
ROA-379.4%
ROIC1351.7%
Valuation
P/E-0.3
P/B-6.6
EV/EBITDA-0.1
Leverage
Debt/Equity0.00
Current Ratio0.64
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-148.82
Beneish M0.00